Accès à distance ? S'identifier sur le proxy UCLouvain
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Primary tabs
- Open access
- 0.96 M
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2024 |
Language | Anglais |
Journal information | "Journal of clinical oncology : official journal of the American Society of Clinical Oncology" - Vol. 42, no. 14, p. 1612-1618 (2024) |
Peer reviewed | yes |
e-issn | 1527-7755 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MONT - Pôle Mont Godinne UCL - (MGD) Service d'hématologie |
Links |
Bibliographic reference | Camus, Vincent ; Thieblemont, Catherine ; Gaulard, Philippe ; Cheminant, Morgane ; Casasnovas, Rene-Olivier ; et. al. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, no. 14, p. 1612-1618 (2024) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/285074 |